Multiple ligands simultaneous molecular docking and dynamics approach to study the synergetic inhibitory of curcumin analogs on ErbB4 tyrosine phosphorylation
Background and purpose: Lapatinib (FMM) and 5-fluorouracil (5-FU) are anticancer drugs employed in a combination approach. FMM inhibits tyrosine phosphorylation of ErbB4 while 5-FU inhibits cell proliferation. This research aimed to investigate the potential of two compounds, namely (1E,4E)-1,5-bis...
Saved in:
Main Authors: | La Ode Aman, Netty Ino Ischak, Teti Sutriyati Tuloli, Arfan Arfan, Aiyi Asnawi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/RPS.RPS_191_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
erbB 基因表达与乳腺癌发生的相关关系
Published: (1998-01-01) -
ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
by: Saffron E. Summers, et al.
Published: (2023-03-01) -
Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01) -
尿液中ErbB3蛋白在肾透明细胞癌早期诊断中的意义
by: 莫承强, et al.
Published: (2018-01-01) -
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
by: Ji-Ji Dao, et al.
Published: (2025-01-01)